Kraig Biocraft Laboratories Secures New Investment License Allowing for Further Production Scale-Up
Kraig Biocraft Laboratories (OTCQB: KBLB) has secured a new investment license in Vietnam, marking a significant milestone in its expansion strategy. This authorization enables the company to scale up its production operations to meet growing demand for its spider silk-based fibers.
The expansion will enhance Kraig Labs' capacity to supply its innovative materials to various markets, including textiles, defense, and medical sectors. The company plans to develop advanced rearing facilities in Vietnam, focusing on environmentally sustainable practices while producing strong, lightweight, and eco-friendly materials.
CEO Kim Thompson emphasized that this license demonstrates confidence in their technology and positions them to expand their production footprint, making cost-effective spider silk production a reality.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha ottenuto una nuova licenza di investimento in Vietnam, segnando un'importante pietra miliare nella sua strategia di espansione. Questa autorizzazione consente all'azienda di aumentare le sue operazioni di produzione per soddisfare la crescente domanda delle sue fibre a base di seta di ragno.
L'espansione migliorerà la capacità di Kraig Labs di fornire i suoi materiali innovativi a diversi mercati, tra cui textile, difesa e settori medicali. L'azienda prevede di sviluppare strutture avanzate di allevamento in Vietnam, concentrandosi su pratiche ambientalmente sostenibili mentre produce materiali forti, leggeri ed ecologici.
Il CEO Kim Thompson ha sottolineato che questa licenza dimostra fiducia nella loro tecnologia e li posiziona per espandere la loro presenza produttiva, rendendo la produzione economica di seta di ragno una realtà.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha obtenido una nueva licencia de inversión en Vietnam, marcando un hito significativo en su estrategia de expansión. Esta autorización permite a la empresa aumentar sus operaciones de producción para satisfacer la creciente demanda de sus fibras a base de seda de araña.
La expansión mejorará la capacidad de Kraig Labs para suministrar sus materiales innovadores a varios mercados, incluidos textiles, defensa y sectores médicos. La empresa planea desarrollar instalaciones avanzadas de crianza en Vietnam, centrándose en prácticas ambientalmente sostenibles mientras produce materiales fuertes, ligeros y ecológicos.
El CEO Kim Thompson enfatizó que esta licencia demuestra confianza en su tecnología y los posiciona para expandir su huella de producción, haciendo realidad la producción rentable de seda de araña.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 베트남에서 새로운 투자 라이센스를 확보하며, 이는 회사의 확장 전략에 있어 중요한 이정표가 됩니다. 이 승인은 회사가 거미실크 기반 섬유에 대한 증가하는 수요를 충족하기 위해 생산 작업을 확대할 수 있도록 합니다.
확장은 Kraig Labs가 섬유, 방위 및 의료 분야를 포함한 다양한 시장에 혁신적인 소재를 공급할 수 있는 능력을 향상시킬 것입니다. 회사는 환경적으로 지속 가능한 관행에 중점을 두어 강하고 가벼우며 친환경적인 소재를 생산하는 고급 사육 시설을 베트남에 개발할 계획입니다.
CEO 킴 톰슨은 이 라이센스가 그들의 기술에 대한 신뢰를 보여주며, 생산 발자취를 확장할 수 있는 위치에 놓이게 한다며, 비용 효율적인 거미 실크 생산을 현실로 만든다고 강조했습니다.
Kraig Biocraft Laboratories (OTCQB: KBLB) a obtenu une nouvelle licence d'investissement au Vietnam, marquant une étape significative dans sa stratégie d'expansion. Cette autorisation permet à l’entreprise d'accroître ses opérations de production pour répondre à la demande croissante de ses fibres à base de soie d'araignée.
L'expansion améliorera la capacité de Kraig Labs à fournir ses matériaux innovants à divers marchés, y compris textiles, défense et secteurs médicaux. L'entreprise prévoit de développer des installations d'élevage avancées au Vietnam, en se concentrant sur des pratiques durables sur le plan environnemental tout en produisant des matériaux solides, légers et écologiques.
Le PDG Kim Thompson a souligné que cette licence démontre la confiance dans leur technologie et les positionne pour étendre leur empreinte de production, rendant la production rentable de soie d’araignée une réalité.
Kraig Biocraft Laboratories (OTCQB: KBLB) hat eine neue Investitionslizenz in Vietnam erhalten, was einen bedeutenden Meilenstein in seiner Expansionsstrategie darstellt. Diese Genehmigung ermöglicht es dem Unternehmen, seine Produktionskapazitäten zu erhöhen, um der wachsenden Nachfrage nach seinen spinnenseidenbasierten Fasern gerecht zu werden.
Die Expansion wird die Fähigkeit von Kraig Labs erhöhen, seine innovativen Materialien an verschiedene Märkte zu liefern, darunter Textilien, Verteidigung und medizinische Sektoren. Das Unternehmen plant, fortschrittliche Aufzuchtanlagen in Vietnam zu entwickeln, mit einem Fokus auf umweltfreundliche Praktiken und die Produktion von starken, leichten und umweltfreundlichen Materialien.
CEO Kim Thompson betonte, dass diese Lizenz Vertrauen in ihre Technologie zeigt und sie in eine Position bringt, um ihre Produktionsbasis zu erweitern, wodurch die kosteneffiziente Herstellung von Spinnenseide Realität wird.
- Secured new investment license in Vietnam enabling production scale-up
- Authorization to expand operations to meet existing material demands
- Potential market expansion into textiles, defense, and medical sectors
- None.
ANN ARBOR, Mich., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a leading developer of spider silk-based fibers, proudly announces that it has received a new investment license in Vietnam. This strategic authorization marks a significant milestone in the Company's mission to expand its production operations to meet the growing demand for its high-performance spider silk materials.
The newly acquired investment license empowers Kraig Labs to scale its production operations significantly and begin addressing the growing requests for materials and requests for quote that it has been fielding. This expansion will bolster the Company's ability to provide its innovative materials to a broad spectrum of markets, including textiles, defense, and medical sectors, eagerly anticipating these breakthrough fibers' commercial availability.
"We are thrilled to secure this new investment license in Vietnam. This license is a testament to our commitment to expanding our production capabilities and the confidence the team placed in our technology," said Founder and CEO of Kraig Labs, Kim Thompson. "This license positions us to grow our production footprint and fulfill the increasing demand for materials. This expansion is moving us forward with our vision for cost-effective spider silk production become a reality."
The Company’s expansion plans in Vietnam include developing advanced rearing facilities and increasing the production of its advanced materials. The Company remains committed to environmentally sustainable practices, leveraging its biotech innovations to deliver materials that are strong, lightweight, and eco-friendly.
This development aligns with Kraig Labs' vision to revolutionize material science by bringing to market one of the most sought-after and impactful biomaterials of the 21st century.
For details about other recent advancements the Company has made, please see the Company's investor conference at www.kraiglabs.com/videos or through the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0030042a-b464-4ac8-b0be-757a79a2fc9a
FAQ
What does the new Vietnam investment license mean for KBLB's production capacity?
Which markets will KBLB target with its expanded spider silk production?
How will KBLB implement its production expansion in Vietnam?
What impact will the Vietnam expansion have on KBLB's market position?
